CVS Health study finds GLP-1 medical savings fall short of drug costs
CVS•CVS Health research found that lower medical spending among GLP-1 users did not offset higher pharmacy spending at current drug prices. Modeling suggested a net price of about $350 per month over three years would balance the costs.
1. Study findings
CVS Health said its analysis linked GLP-1 use to better clinical outcomes, fewer hospitalizations and lower medical spending, but those savings did not fully offset higher pharmacy spending at current prices. The analysis compared commercially insured Aetna GLP-1 users with matched non-users whose treatment began from 2023 through 2025. Modeling suggested a net price of approximately $350 per month over three years would balance pharmacy spending with observed medical savings. Dr. Amy Compton-Phillips was scheduled to discuss the findings at the HLTH industry conference in Las Vegas.
